Evogene Ltd.EVGNNASDAQ
Loading
Operating Income Growth Under PressureDecelerating
Percentile Rank77
3Y CAGR+0.7%
Year-over-Year Change
Year-over-year operating income growth rate
3Y CAGR
+0.7%/yr
Quarterly compound
Percentile
P77
Within normal range
vs 3Y Ago
1x
Modest growth
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q3 2025 | 11.59% |
| Q2 2025 | 28.86% |
| Q1 2025 | 5.47% |
| Q4 2024 | 22.85% |
| Q3 2024 | -28.03% |
| Q2 2024 | -29.63% |
| Q1 2024 | 53.24% |
| Q4 2023 | -82.36% |
| Q3 2023 | 47.06% |
| Q2 2023 | -16.26% |
| Q1 2023 | 6.67% |
| Q4 2022 | -2.61% |
| Q3 2022 | 11.37% |
| Q2 2022 | 0.60% |
| Q1 2022 | 7.33% |
| Q4 2021 | -1.59% |
| Q3 2021 | -14.91% |
| Q2 2021 | -18.96% |
| Q1 2021 | 12.79% |
| Q4 2020 | -29.25% |
| Q3 2020 | -6.26% |
| Q2 2020 | 23.80% |
| Q1 2020 | 0.33% |
| Q4 2019 | -40.06% |
| Q3 2019 | -4.47% |
| Q2 2019 | -0.73% |
| Q1 2019 | 11.35% |
| Q4 2018 | -3.21% |
| Q3 2018 | -9.20% |
| Q2 2018 | 5.52% |
| Q1 2018 | 17.83% |
| Q4 2017 | -9.40% |
| Q3 2017 | -6.48% |
| Q2 2017 | 1.75% |
| Q1 2017 | 14.52% |
| Q4 2016 | -18.95% |
| Q3 2016 | 0.17% |
| Q2 2016 | -13.02% |
| Q1 2016 | 14.62% |
| Q4 2015 | -41.96% |